Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lady-Comp offers risk-free, natural and healthy method of contraception and family planning as new study shows birth control pills increase risk for breast cancer
  • USA - English


News provided by

Lady-Comp UK

Jan 29, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Join the thousands of women worldwide, who are already enjoying Lady-Comp®
Join the thousands of women worldwide, who are already enjoying Lady-Comp®

London, UK (PRWEB UK) 29 January 2014 -- New study shows oral contraceptive usage increases risk for breast cancer.

This product is a definite MUST if you are looking to come off invasive / hormone-altering methods of contraception and try something more natural - the Lady-Comp is accurate and easy to use without having to worry about nasty hormonal side effects.

Post this

Despite the World Health Organization’s classification of oral contraceptives as a Group 1 carcinogen, medical professionals across the globe persist in their prescription of the pill as a comprehensive, “one-size-fits-all” medical solution for women. A recent study published in the Indian Journal of Cancer adds to the growing research literature denoting a link between oral contraceptive use and increased health risk for breast cancer. In this study of 640 women – 320 women with newly diagnosed breast cancer and 300 healthy women – doctors in India found that the risk of breast cancer was almost 10 times higher in women who had a medical history of oral contraceptive usage.

The heightened risk for breast cancer stemming from oral contraceptive use was found to be higher than the other risk factors explored in the study, save for a lack of breastfeeding as a factor. For more comprehensive study results, the two groups of women in the study had similar demographic characteristics, including age, socioeconomic status, and medical background.

Other effects associated with birth control pills and IUDs (coils)

Many users of oral contraceptives are unaware of the side effects, short- and long-term, which oral contraceptives can engender. Other research literature documents that the taking of birth control pills are associated with pronounced, short- and long-term effects including:

• Headaches, migraines, or dizziness
• Changes in appearance—acne breakouts or loss of scalpel hair
• Cerebral hemorrhaging or thrombosis (bleeding that occurs in the cranial cavity; blood clot which can lead to draining of blood from the brain)
• Appearance of mental depression
• Increased nervousness
• Cataracts
• Altered structure of the cornea
• Hypertension
• Gallbladder disease
• Hemolytic uremic syndrome (kidney failure and low platelet count in the blood)

Additionally, many fertility experts (including doctors) are concerned about the fact that women often are not informed that the birth control pill can cause an chemical abortion as well as prevent pregnancy. Despite the hormones’ ability to prevent the release of eggs, sometimes a “breakthrough ovulation” takes place.

A woman can still conceive a baby (embryo), who because of synthetic hormones cannot attach to the uterine lining and is aborted. The pill’s third mechanism is to change the lining of the endometrium, which creates a hostile environment for a newly created human life.

The similar and even worse mechanism works in case of IUDs (coils), like Mirena, where one of the mechanisms incorporates a physical intrusion to prevent implantation of already conceived baby (embryo).

More information about the pill’s harmful side effects can be found here.

Lady-Comp, a reliable and natural birth control alternative to invasive contraception

Women who are health-conscious have a safe, reliable alternative for contraception in Lady-Comp, a state-of-the-art fertility computer that monitors fertility with 99.3% clinically proven accuracy. The fertility calculator has been engineered to carefully track a woman’s fertility by drawing upon advanced bio-mathematical forecasting and extensive information drawn from over 900,000 cycles of thousands of women with unique fertilities.

Lady-Comp also leverages specialized computer software to track, monitor, and store a woman’s unique fertility information. Over time, it uses an advanced machine learning ability to adjust itself to a woman’s unique cycle, regardless of any irregularities or cycle length. All is required is that its user take a daily temperature reading, which takes only 30 seconds, and the user is quickly made aware of her fertility status.

Easy to use and convenient

Usually a woman has six days in her cycle in which she can become pregnant: five days before ovulation and the sixth day on which she ovulates. On that final day, women see a slight rise in their body temperature. This is the measure that Lady-Comp precisely detects, measures, and then compares to previously compiled data for fertility status monitoring.

A simple, three-color system (red, yellow, and green) indicates fertility status instantly after temperature taking. Green denotes when one is infertile, red when one is fertile, and yellow when the machine is in the stage of learning its user’s unique fertility patterns. Lady-Comp makes up for missing temperature measurements as well.

Lady-Comp does not feature any recurring costs, has up to a 10-year life expectancy, and is backed by customer support as well as an optional extended 3-year warranty. Payment plans are available for those who would prefer to avoid an upfront, one-time payment.

More information about Lady-Comp’s premium efficacy, proven safeguarding against health risks associated with oral contraceptive use, and other benefits can be found at: https://www.lady-comp.co.uk.

The Times of India article which covered the breast cancer risk factors study can be found at: http://articles.timesofindia.indiatimes.com/2014-01-02/delhi/45798173_1_breast-cells-breast-cancer-institute-rotary-cancer-hospital.

About Lady-Comp:

Lady-Comp UK is the only authorised distributor of Lady-Comp® for the UK and Ireland – the most effective fertility & natural birth control & family planning computer available on the market.

Luke Manczak, Lady-Comp UK, http://www.lady-comp.co.uk, +353 871357699, [email protected]

Modal title

The World Health Organization officially labels combined oral contraceptives as a Group 1 Carcinogen
The World Health Organization officially labels combined oral contraceptives as a Group 1 Carcinogen
Lady Comp - natural contraception for every healthy conscious woman
Lady Comp - natural contraception for every healthy conscious woman
The World Health Organization officially labels combined oral contraceptives as a Group 1 Carcinogen Lady Comp - natural contraception for every healthy conscious woman

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.